Elcelyx Therapeutics

Elcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. ElcelyxвАЩs proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b developmen...